Qing-Luo-Yin Alleviated Monocytes/Macrophages-Mediated Inflammation in Rats with Adjuvant-Induced Arthritis by Disrupting Their Interaction with (Pre)-Adipocytes Through PPAR-γ Signaling

References

• CopeAP. T cells in rheumatoid arthritis. Arthritis Res Ther. 2008;10:S1. doi:10.1186/ar2412
   PubMed Web of Science ®Google Scholar
• TohML, MiossecP. The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr Opin Rheumatol. 2007;19:284–288. doi:10.1097/BOR.0b013e32805e87e017414957
   PubMed Web of Science ®Google Scholar
• LevesqueD. Biologic rheumatoid arthritis therapies. Biodrugs. 2012;26:65–70. doi:10.2165/11631320-000000000-0000022385403
   PubMed Web of Science ®Google Scholar
• DavignonJL, HayderM, BaronM, et al. Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Rheumatology. 2013;4:590–598. doi:10.1093/rheumatology/kes304
   Web of Science ®Google Scholar
• Petrovic-RackovL, PejnovicN. Clinical significance of IL-18, IL-15, IL-12 and TNF-α measurement in rheumatoid arthritis. Clin Rheumatol. 2006;25:448–452. doi:10.1007/s10067-005-0106-016362448
   PubMed Web of Science ®Google Scholar
• AliL, SchnitzlerJG, KroonJ. Metabolism: the road to inflammation and atherosclerosis. Curr Opin Lipidol. 2018;29:474–480. doi:10.1097/MOL.000000000000055030234554
   PubMed Web of Science ®Google Scholar
• TravelliC, ColomboG, MolaS, et al. NAMPT: a pleiotropic modulator of monocytes and macrophages. Pharmacol Res. 2018;135:25–36. doi:10.1016/j.phrs.2018.06.02230031171
   PubMed Web of Science ®Google Scholar
• ParkSY, LeeSW, KimHY, et al. SIRT1 inhibits differentiation of monocytes to macrophages: amelioration of synovial inflammation in rheumatoid arthritis. J Mol Med. 2016;94:921–931. doi:10.1007/s00109-016-1402-726956118
   PubMed Web of Science ®Google Scholar
• AbdallaHB, NapimogaMH, LopesAH, et al. Activation of PPAR-γ induces macrophage polarization and reduces neutrophil migration mediated by heme oxygenase 1. Int Immunopharmacol. 2020;84:106565. doi:10.1016/j.intimp.2020.10656532388213
   PubMed Web of Science ®Google Scholar
• AfeltraA, AbbateA, ValentiniG, et al. Inflammation and dysmetabolism in systemic autoimmune diseases. J Immunol Res. 2019;2019:5438287. doi:10.1155/2019/543828731428657
   PubMed Web of Science ®Google Scholar
• KammounHL, KraakmanMJ, FebbraioMA. Adipose tissue inflammation in glucose metabolism. Rev Endocr Metab Disord. 2014;15:31–44. doi:10.1007/s11154-013-9274-424048715
   PubMed Web of Science ®Google Scholar
• ZhangB, WangX, LiS. An integrative platform of TCM network pharmacology and its application on a herbal formula, Qing-Luo-Yin. Evid Based Complement Alternat Med. 2013;2013:456747.23653662
   PubMed Web of Science ®Google Scholar
• LiS, LuAP, WangYY, et al. Suppressive effects of a Chinese herbal medicine Qing-Luo-Yin extract on the angiogenesis of collagen-induced arthritis in rats. Am J Chin Med. 2003;31:713–720. doi:10.1142/S0192415X0300143014696674
   PubMed Web of Science ®Google Scholar
• LiY, LiR, OuyangZ, et al. Herb network analysis for a famous TCM doctor’s prescriptions on treatment of rheumatoid arthritis. Evid Based Complement Alternat Med. 2015;2015:451319.25983850
   PubMed Web of Science ®Google Scholar
• ZuoJ, WangX, LiuY, et al. Integrating network pharmacology and metabolomics study on anti-rheumatic mechanisms and antagonistic effects against methotrexate-induced toxicity of Qing-Luo-Yin. Front Pharmacol. 2018;2018:1472. doi:10.3389/fphar.2018.01472
   Web of Science ®Google Scholar
• ZuoJ, TaoMQ, WuXY, et al. Securidaca inappendiculata-derived xanthones protected joints from degradation in male rats with collagen-induced arthritis by regulating PPAR-γ signaling. J Inflamm Res. 2021;14:395–411. doi:10.2147/JIR.S29595733623411
   PubMed Web of Science ®Google Scholar
• EmingSA, WynnTA, MartinP. Inflammation and metabolism in tissue repair and regeneration. Science. 2017;356:1026–1030. doi:10.1126/science.aam792828596335
   PubMed Web of Science ®Google Scholar
• ZhangC, WangK, YangL, et al. Lipid metabolism in inflammation-related diseases. Analyst. 2018;143:4526–4536. doi:10.1039/C8AN01046C30128447
   PubMed Web of Science ®Google Scholar
• HarmonGS, LamMT, GlassCK. PPARs and lipid ligands in inflammation and metabolism. Chem Rev. 2011;111:6321–6340. doi:10.1021/cr200135521988241
   PubMed Web of Science ®Google Scholar
• McInnesIB, SchettG. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219. doi:10.1056/NEJMra100496522150039
   PubMed Web of Science ®Google Scholar
• WoodworthTG, BroederAD. Treating to target in established rheumatoid arthritis: challenges and opportunities in an era of novel targeted therapies and biosimilars. Best Pract Res: Clin Rheumatol. 2015;29:543–549. doi:10.1016/j.berh.2015.10.00126697765
   PubMed Web of Science ®Google Scholar
• SchusterS, EwaldJ, KaletaC. Modeling the energy metabolism in immune cells. Curr Opin Biotechnol. 2021;68:282–291. doi:10.1016/j.copbio.2021.03.00333770632
   PubMed Web of Science ®Google Scholar
• YangY, WeiJ, LiJ, et al. Lipid metabolism in cartilage and its diseases: a concise review of the research progress. Acta Biochim Biophys Sin. 2021;53:517–527. doi:10.1093/abbs/gmab02133638344
   PubMedGoogle Scholar
• YangZ, MattesonEL, GoronzyJJ, et al. T-cell metabolism in autoimmune disease. Arthritis Res Ther. 2015;17:29. doi:10.1186/s13075-015-0542-425890351
   PubMed Web of Science ®Google Scholar
• KwonEJ, ParkEJ, ChoiS, et al. PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes. Int J Rheum Dis. 2017;20:1499–1509. doi:10.1111/1756-185X.1291327456070
   PubMed Web of Science ®Google Scholar
• OnuoraS. Rheumatoid arthritis. How bad is obesity for RA? Nat Rev Rheumatol. 2012;8:306. doi:10.1038/nrrheum.2012.78
   Web of Science ®Google Scholar
• van EekerenIC, ClockaertsS, Bastiaansen-JenniskensYM, et al. Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review. Ther Adv Musculoskelet Dis. 2013;5:33–44. doi:10.1177/1759720X1246865923515070
   PubMedGoogle Scholar
• FullertonJN, O’BrienAJ, GilroyDW. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol. 2014;35:12–21. doi:10.1016/j.it.2013.10.00824268519
   PubMed Web of Science ®Google Scholar
• BakerJF, BilligE, MichaudK, et al. Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. Arthritis Rheumatol. 2015;67:1711–1717. doi:10.1002/art.3913625940140
   PubMed Web of Science ®Google Scholar
• GiaginisC, GiaginiA, TheocharisS. Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis. Pharmacol Res. 2009;60:160–169. doi:10.1016/j.phrs.2009.02.00519646655
   PubMed Web of Science ®Google Scholar
• ScoteceM, CondeJ, GómezR, et al. Beyond fat mass: exploring the role of adipokines in rheumatic diseases. Sci World J. 2011;11:1932–1947. doi:10.1100/2011/290142
   Web of Science ®Google Scholar
• SenoltL, PavelkaK, HousaD, HaluzíkM. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine. 2006;35:247–252. doi:10.1016/j.cyto.2006.09.00217079158
   PubMed Web of Science ®Google Scholar